-
抗体試薬
- フローサイトメトリー用試薬
-
ウェスタンブロッティング抗体試薬
- イムノアッセイ試薬
-
シングルセル試薬
- BD® OMICS-Guard Sample Preservation Buffer
- BD® OMICS-One Protein Panels
- BD® AbSeq Assay
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ ATAC-Seq Assays
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Immune Profiler Protein Panel
-
細胞機能評価のための試薬
-
顕微鏡・イメージング用試薬
-
細胞調製・分離試薬
-
- BD® OMICS-Guard Sample Preservation Buffer
- BD® OMICS-One Protein Panels
- BD® AbSeq Assay
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ ATAC-Seq Assays
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Immune Profiler Protein Panel
- Japan (Japanese)
-
Change location/language
Old Browser
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Thought Leadership
Flow Cytometry News
Be part of the flow cytometry community with the latest flow cytometry news, thought leader opinions, blogs on breakthrough research, interesting flow cytometry publication reviews, and more.
We are in a global pandemic. As the COVID-19 pandemic continues to spread worldwide, there is a pressing need to understand the biological mechanisms determining disease progression and severity.
A complex interaction of anabolic and catabolic metabolism underpins the ability of leukocytes to mount an immune response. Their capacity to respond to changing environments by metabolic reprogramming is crucial to effector function.